Childhood Vaccinations: Benefits, Risks, and Ethical Issues
This paper examines the debate surrounding childhood vaccinations, weighing the documented benefits of immunization against concerns raised by parents and researchers. It traces the history of active immunity and vaccine development, reviews the CDC's recommended early childhood vaccination schedule, and analyzes the controversial 1998 Wakefield study linking the MMR vaccine to autism. The paper also addresses the major ethical dimensions of vaccine policy, including government mandates, research ethics, informed consent requirements under the National Childhood Vaccine Injury Act of 1986, and socioeconomic disparities in vaccine access. The paper concludes that current evidence continues to support routine childhood vaccination.
- Introduction: Vaccine safety debate and immunization rates
- Positives for Vaccinations: Active immunity and benefits of vaccination
- Recommended Vaccination Schedule: CDC early childhood vaccination timetable
- Negatives for Vaccinations: Wakefield study and autism controversy
- Ethical Issues: Mandates, consent, and access disparities
- Conclusion: Evidence supports continued childhood vaccination
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Presents a balanced structure that addresses both pro-vaccination evidence and legitimate parental concerns without dismissing either side prematurely.
- Grounds the ethical discussion in concrete legal frameworks, specifically the National Childhood Vaccine Injury Act of 1986, adding practical specificity to what could otherwise remain abstract.
- Incorporates a data table (CDC vaccination schedule) to support the informational sections and give the reader a concrete reference point.
- Closes with a defensible, evidence-based conclusion rather than false equivalence, reinforcing the paper's public health perspective.
Key academic technique demonstrated
The paper demonstrates effective use of source-based argumentation at the introductory level: each major claim — from the benefits of active immunity to the autism controversy to ethical mandates — is supported by a cited source. The treatment of the Wakefield study is particularly instructive, as it accurately represents what the study claimed and did not claim, modeling careful reading of primary research.
Structure breakdown
The paper follows a classic problem–counterargument–synthesis structure across six sections. The introduction frames the central tension between vaccine safety and coverage rates. Two body sections cover the affirmative and negative cases. A dedicated ethical issues section broadens the debate beyond purely medical claims. The conclusion synthesizes all threads and restates the pro-vaccination position with qualification, acknowledging the need for informed parental decision-making.
Introduction
Vaccines against diphtheria, polio, pertussis, measles, mumps and rubella, and more recent additions of hepatitis B and chickenpox, have given humans powerful immune defenses to ward off serious illness. Thanks to state laws that require vaccinations for children enrolling in kindergarten, the United States presently enjoys its highest immunization rate ever, at approximately 77%. Yet beneath these national numbers lies an ongoing debate about vaccine safety. Driven by claims that vaccinations may be associated with autism, a growing number of parents are raising questions about whether vaccines are in fact harmful to children rather than helpful (Park, 2008).
Positives for Vaccinations
For many years before the development of vaccines, it was understood that after recovering from certain diseases, some people would not become infected when exposed to those diseases again. The process by which a person is protected from a disease following natural infection is termed active immunity. The person is protected because the immune system remembers the past infection and reacts quickly upon subsequent exposure. For diseases that can be life-threatening, however, attaining immunity this way carries the risk of death upon the first encounter. Even for non-life-threatening diseases, many infections carry a risk of serious complications, so it is preferable to obtain immunity without taking unnecessary risks. Active immunity through vaccination presents a much safer alternative (Childhood Vaccinations: Understanding Vaccines, 2006).
The CDC works closely with public health agencies and private partners to improve and sustain immunization coverage and to monitor vaccine safety, so that public health can be maintained and expanded in the future.
Recommended Vaccination Schedule
The table below lists the recommended and minimum ages for early childhood vaccinations, as approved by the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, and the American Academy of Family Physicians.
Table 1 — Recommended and Minimum Ages for Early Childhood Vaccinations
Hepatitis B
Dose 1: Recommended age 0–2 months; minimum acceptable age: birth.
Dose 2: Recommended age 1–4 months; minimum interval from prior dose: 4 weeks.
Dose 3: Recommended age 6–18 months; minimum acceptable age: 6 months; minimum interval: 8 weeks.
DTP (diphtheria and tetanus toxoids and acellular or whole-cell pertussis vaccine)
Dose 1: Recommended age 2 months; minimum acceptable age: 6 weeks.
Dose 2: Recommended age 4 months; minimum acceptable age: 10 weeks; minimum interval: 4 weeks.
Dose 3: Recommended age 6 months; minimum acceptable age: 14 weeks; minimum interval: 4 weeks.
Dose 4: Recommended age 15–18 months; minimum acceptable age: 12 months; minimum interval: 4 months.
Haemophilus influenzae type b (Hib)
Dose 1: Recommended age 2 months; minimum acceptable age: 6 weeks.
Dose 2: Recommended age 4 months; minimum acceptable age: 10 weeks; minimum interval: 4 weeks.
Dose 3: Recommended age 6 months; minimum acceptable age: 14 weeks; minimum interval: 4 weeks. (Not needed if PRP-OMP vaccine used for doses 1 and 2.)
Dose 4: Recommended age 12–15 months; minimum acceptable age: 12 months; minimum interval: 8 weeks.
Poliovirus
Dose 1: Recommended age 2 months; minimum acceptable age: 6 weeks.
Dose 2: Recommended age 4 months; minimum acceptable age: 10 weeks; minimum interval: 4 weeks.
Dose 3: Recommended age 6–18 months; minimum acceptable age: 14 weeks; minimum interval: 4 weeks.
Measles-Mumps-Rubella (MMR)
Dose 1: Recommended age 12–15 months; minimum acceptable age: 12 months.
Varicella
Dose 1: Recommended age 12–18 months; minimum acceptable age: 12 months.
Note: Doses given within 4 days before the minimum age or minimum interval for any vaccine are considered acceptable. In most cases 4 doses of Hib are recommended; however, the 6-month dose is not needed if haemophilus b conjugate (PRP-OMP) (PedvaxHIB or ComVax [Merck]) is used for the 2- and 4-month doses.
Source: Carolyn Drews-Botsch et al. (2005)
Conclusion
There is no denying that vaccines have been beneficial over the years. Many deadly diseases that earlier generations had to fear are today rarely given a second thought. On the other hand, some studies have claimed to find a link between vaccinations and disorders such as autism. Ultimately, parents must educate themselves in order to make the best decision regarding immunizing their children. In a study by Tarrant and Thomson (2008), parents readily acknowledged that they had gaps in their knowledge about childhood vaccines, but believed that the benefits of immunization outweighed any risks that might be present. The most common sources of information for these parents were family members and peers. In addition, broad public health programs and mandatory vaccination requirements for school entry helped ensure that childhood immunization recommendations were followed.
At this time, there does not appear to be sufficient evidence to recommend that children not be vaccinated. The benefits of childhood vaccination clearly outweigh any possible harm the vaccinations might cause. Children should continue to be vaccinated according to the schedule established by the CDC, so that the population at large can remain protected.
Works Cited
Carolyn Drews-Botsch, et al. "Timeliness of Childhood Immunizations: A State-Specific Analysis." American Journal of Public Health 95.8 (2005): 1367–1374. Business Source Premier. Web. 22 Nov. 2011.
"Childhood Vaccinations: Understanding Vaccines." Practice Nurse 31 (2006): 9–13. Business Source Premier. Web. 22 Nov. 2011.
"Ethical Issues and Vaccines." The History of Vaccines. 2011. Web. 22 Nov. 2011.
Park, Alice. "How Safe Are Vaccines?" Time Magazine. 2008. Web. 22 Nov. 2011.
Tarrant, Marie, and Neil Thomson. "Secrets to Success: A Qualitative Study of Perceptions of Childhood Immunisations in a Highly Immunised Population." Journal of Paediatrics and Child Health 44.10 (2008): 541–547. PsycINFO. Web. 22 Nov. 2011.
Create your account
Always verify citation format against your institution’s current style guide requirements.